Zymeworks Inc.

NYSE:ZYME

16.77 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 1619.24310.0316.92616.5067.00235.578402.4932.6315.4421.91619.874.3951.7710.64415.682.64312.3598.2691.8777.867.88211.92528.9252.054220.0450.0710.1191.3420.232.2322.1726.3430.2621.439
Cost of Revenue 2.6632.52932.74225.22532.94339.40845.41353.44937.09756.02262.5154.68349.89350.71144.28339.76854.40139.21736.94345.38929.25123.78517.47514.27814.19515.36813.08512.0211.5258.2898.847.6539.75910.2237.9167.986
Gross Profit 13.33716.714-22.712-8.299-16.437-32.406-9.835349.044-34.466-50.58-60.594-34.813-45.498-48.94-43.639-24.088-51.758-26.858-28.674-43.512-21.391-15.903-5.5514.647-12.1416.632-13.04538.051-11.406-6.947-8.61-5.421-7.587-3.88-7.654-6.547
Gross Profit Ratio 0.8340.869-2.264-0.49-0.996-4.628-0.2760.867-13.1-9.294-31.625-1.752-10.352-27.634-67.762-1.536-19.583-2.173-3.468-23.182-2.722-2.018-0.4650.506-5.9110.301-326.1250.76-95.849-5.177-37.435-2.429-3.493-0.612-29.214-4.55
Reseach & Development Expenses 16,00029.16332.04225.52416.50639.40845.91252.96737.09756.02262.5154.86549.89350.71144.28339.2653.53139.21736.52645.3897,86023.78517.47514.08914.14215.36813.08512.87711.5258.2899.0588.9189.75910.2237.9168.237
General & Administrative Expenses 13,85215.715.7914.77716.96821.70816.94730.13115.89215.24312.0925.85415.46619.9451.29613.96522.80613.4917.62330.2412.17312.7619.0036.2967.4478.6487.0664.7155.2912.2856.2595.1172.6962.6562.0851.371
Selling & Marketing Expenses 0-15,665.850000000000000000000000000000000000
SG&A 13,85213.1515.7914.77716.96821.70816.94730.13115.89215.24312.0925.85415.46619.9451.29613.96522.80613.4917.62330.2412.17312.7619.0036.2967.4478.6487.0664.7155.2912.2856.2595.1172.6962.6562.0851.371
Other Expenses 20,3530.0530.019-0.27816.2690.234.3181.041-0.0980.0360.0470.326-0.004-0.0940.192-0.187-0.065-0.0130.0271.00621,39116.6715.551.08312,088013.045-0.33400-0.218-1.2650000
Operating Expenses 50,20542.31347.83240.30149.74361.11662.85983.09852.98971.26574.60260.71965.35970.65645.57953.22576.33752.70844.14975.62912.17336.54626.47820.3921.58924.01620.15116.73516.81610.57415.09912.7712.45512.87910.0011.399
Operating Income -34,205-25.599-37.802-23.421-33.237-54.114-27.281319.395-50.358-65.823-72.686-40.849-60.964-68.885-44.935-37.545-73.694-40.349-35.88-73.752-33.564-29.432-14.5538.535-19.535-2.016-20.11133.336-16.697-9.232-16.405-10.538-11.051-6.536-9.739-7.918
Operating Income Ratio -2,137.813-1.33-3.769-1.384-2.014-7.728-0.7670.794-19.14-12.095-37.936-2.056-13.871-38.896-69.775-2.394-27.883-3.265-4.339-39.292-4.27-3.734-1.220.295-9.511-0.092-502.7750.666-140.311-6.879-71.326-4.721-5.088-1.03-37.172-5.502
Total Other Income Expenses Net 4,581-12.0190.304-0.8325.66-0.2094.3181.0412.4830.759-0.0130.3260.8090.3410.129-0.187-0.213-0.1783.251.0060.117-0.946-0.1391.083-0.132-2.283-1.408-0.3340.294-1.76-0.88-0.603-1.699-0.4191.5750.027
Income Before Tax -29,624-37.618-31.578-19.204-27.577-49.498-22.963320.436-47.875-64.628-72.699-40.523-59.815-67.956-44.065-37.732-72.605-39.025-30.761-72.746-31.383-28.442-13.4489.618-18.702-4.032-21.26933.002-16.195-10.843-15.926-11.272-12.142-7.351-8.119-7.891
Income Before Tax Ratio -1,851.5-1.955-3.148-1.135-1.671-7.069-0.6450.796-18.197-11.876-37.943-2.039-13.61-38.372-68.424-2.406-27.471-3.158-3.72-38.757-3.993-3.608-1.1280.333-9.105-0.183-531.7250.659-136.092-8.08-69.243-5.05-5.59-1.159-30.989-5.484
Income Tax Expense -2260.0680.075-4.722-1.111.6541.3911.005-0.029-0.009-0.074-1.3710.764-0.4340.5250.161-0.043-0.0640.375-0.502-0.9080.6350.1930.3450.0491.842-0.0650.2690.050.1250.1390.0050.2550.072-5.4070.034
Net Income -29,850-37.686-31.653-14.482-28.687-51.152-24.353309.431-47.846-64.619-72.625-39.152-60.579-67.522-44.59-37.893-72.562-38.961-31.136-72.244-30.475-29.077-13.6419.273-18.751-5.874-21.20432.733-16.245-10.968-15.926-11.277-12.397-7.423-2.712-7.925
Net Income Ratio -1,865.625-1.958-3.156-0.856-1.738-7.305-0.6840.769-18.185-11.874-37.904-1.97-13.784-38.126-69.239-2.417-27.454-3.152-3.765-38.489-3.877-3.689-1.1440.321-9.129-0.267-530.10.654-136.513-8.173-69.243-5.052-5.708-1.17-10.351-5.507
EPS -392.1-0.49-0.42-0.2-0.41-0.76-0.364.65-0.72-0.97-1.18-0.76-1.17-1.31-0.87-0.74-1.43-0.77-0.64-1.66-0.7-0.89-0.430.29-0.59-0.22-0.831.29-0.64-0.52-0.81-0.57-0.62-0.37-0.14-0.7
EPS Diluted -391.95-0.49-0.42-0.2-0.41-0.76-0.364.65-0.72-0.97-1.18-0.75-1.16-1.31-0.87-0.74-1.43-0.77-0.64-1.66-0.7-0.89-0.430.29-0.59-0.22-0.831.28-0.64-0.52-0.81-0.57-0.62-0.37-0.14-0.7
EBITDA -34,205-23.07-35.775-19.473-33.237-49.158-27.281319.395-49.621-64.374-66.993-40.849-59.016-66.56-42.252-37.545-70.873-37.919-36.286-73.752-29.782-25.846-11.8138.535-17.388-0.985-19.13433.336-15.769-8.376-14.319-10.043-10.279-6.431-9.507-7.634
EBITDA Ratio -2,137.813-1.199-3.567-1.15-2.014-7.021-0.7670.794-18.86-11.829-34.965-2.056-13.428-37.583-65.609-2.394-26.815-3.068-4.388-39.292-3.789-3.279-0.9910.295-8.465-0.045-478.350.666-132.513-6.241-62.257-4.5-4.733-1.014-36.286-5.305